Free Trial

NanoViricides (NNVC) Competitors

NanoViricides logo
$1.12 -0.07 (-5.88%)
Closing price 03:59 PM Eastern
Extended Trading
$1.12 +0.00 (+0.45%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NNVC vs. FBLG, VHAQ, ZIVO, RVPH, ANVS, ONCY, SLS, BYSI, MURA, and IMRX

Should you be buying NanoViricides stock or one of its competitors? The main competitors of NanoViricides include FibroBiologics (FBLG), Viveon Health Acquisition (VHAQ), ZIVO Bioscience (ZIVO), Reviva Pharmaceuticals (RVPH), Annovis Bio (ANVS), Oncolytics Biotech (ONCY), SELLAS Life Sciences Group (SLS), BeyondSpring (BYSI), Mural Oncology (MURA), and Immuneering (IMRX). These companies are all part of the "pharmaceutical products" industry.

NanoViricides vs.

FibroBiologics (NASDAQ:FBLG) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, community ranking, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

FibroBiologics received 7 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 100.00% of users gave FibroBiologics an outperform vote while only 0.00% of users gave NanoViricides an outperform vote.

CompanyUnderperformOutperform
FibroBiologicsOutperform Votes
7
100.00%
Underperform Votes
No Votes
NanoViricidesOutperform Votes
No Votes
Underperform Votes
57
100.00%

FibroBiologics currently has a consensus target price of $13.00, indicating a potential upside of 655.81%. Given FibroBiologics' stronger consensus rating and higher possible upside, equities research analysts clearly believe FibroBiologics is more favorable than NanoViricides.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FibroBiologics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
NanoViricides
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FibroBiologicsN/AN/A-$16.49MN/AN/A
NanoViricidesN/AN/A-$8.29M-$0.76-1.49

10.3% of NanoViricides shares are owned by institutional investors. 20.8% of FibroBiologics shares are owned by insiders. Comparatively, 4.6% of NanoViricides shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

FibroBiologics' return on equity of 0.00% beat NanoViricides' return on equity.

Company Net Margins Return on Equity Return on Assets
FibroBiologicsN/A N/A -225.34%
NanoViricides N/A -84.63%-76.49%

In the previous week, FibroBiologics' average media sentiment score of 0.00 equaled NanoViricides'average media sentiment score.

Company Overall Sentiment
FibroBiologics Neutral
NanoViricides Neutral

Summary

FibroBiologics beats NanoViricides on 8 of the 11 factors compared between the two stocks.

Get NanoViricides News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NNVC vs. The Competition

MetricNanoViricidesPharmaceutical IndustryMedical SectorNYSE Exchange
Market Cap$15.83M$6.55B$5.38B$20.04B
Dividend YieldN/A2.96%5.37%3.61%
P/E Ratio-1.499.7087.8141.66
Price / SalesN/A334.591,285.9917.77
Price / CashN/A22.6336.6017.54
Price / Book1.175.064.945.85
Net Income-$8.29M$154.90M$117.96M$1.01B
7 Day Performance-3.81%2.31%2.29%3.48%
1 Month Performance-23.83%1.25%3.26%5.99%
1 Year Performance6.07%4.88%27.03%20.49%

NanoViricides Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NNVC
NanoViricides
N/A$1.12
-5.9%
N/A+11.2%$15.62MN/A-1.4720Gap Up
FBLG
FibroBiologics
1.9205 of 5 stars
$1.94
+3.2%
$13.00
+570.1%
N/A$68.07MN/A0.0010
VHAQ
Viveon Health Acquisition
N/A$10.00
flat
N/AN/A$66.49MN/A0.002
ZIVO
ZIVO Bioscience
N/A$18.35
-3.9%
N/A+178.3%$66.45M$15,850.00-3.7610
RVPH
Reviva Pharmaceuticals
3.8045 of 5 stars
$1.98
+5.2%
$11.25
+469.0%
-56.9%$66.12MN/A-1.785Analyst Forecast
Options Volume
Gap Up
ANVS
Annovis Bio
2.2648 of 5 stars
$4.79
-2.0%
$31.40
+555.5%
-57.1%$66.09MN/A-1.073
ONCY
Oncolytics Biotech
1.3791 of 5 stars
$0.82
-5.3%
$4.00
+385.9%
-34.6%$65.87MN/A-3.0530
SLS
SELLAS Life Sciences Group
0.1985 of 5 stars
$0.93
-2.4%
N/A+101.3%$65.46M$1M-1.3510Gap Up
BYSI
BeyondSpring
N/A$1.63
-1.8%
N/A+95.0%$63.62M$1.88M0.0080Positive News
Gap Down
MURA
Mural Oncology
3.3179 of 5 stars
$3.73
-4.1%
$16.00
+329.0%
-4.3%$63.49MN/A-0.41119Positive News
Gap Down
IMRX
Immuneering
3.6686 of 5 stars
$2.03
-1.9%
$12.80
+530.5%
-65.8%$63.03M$320,000.00-1.0360Gap Up

Related Companies and Tools


This page (NYSE:NNVC) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners